Medications with narrow therapeutic windows (like warfarin, levothyroxine, or certain diabetes medications) may need dose adjustments when combined with semaglutide
Clinical trials show constipation occurs in 1525% of people on semaglutide, depending on dose and individual genetics
doi: 10.1056/NEJMoa2028198
GLP-1 + GIP receptor agonist Targets two metabolic hormone receptors (GLP-1 and GIP) that help regulate appetite, support fullness, and improve blood sugar control
This requires careful monitoring of thyroid function tests to ensure that patients maintain an appropriate level of thyroid hormone replacement as they lose weight
Cold Storage and Access Challenges: The Final Hurdle in GLP-1 Availability While the FDA may determine that the national supply of tirzepatide and other GLP-1 medications is sufficient to meet market demand, the reality for patients often tells a different story